UroGen Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.

About URGN

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.

CEO

Elizabeth Barrett

CEOElizabeth Barrett

Employees

235

Employees235

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

2004

Founded2004

Employees

235

Employees235

URGN Key Statistics

Market cap

918.81M

Market cap918.81M

Price-Earnings ratio

-5.98

Price-Earnings ratio-5.98

Dividend yield

—

Dividend yield—

Average volume

842.81K

Average volume842.81K

High today

$20.20

High today$20.20

Low today

$19.17

Low today$19.17

Open price

$19.73

Open price$19.73

Volume

686.64K

Volume686.64K

52 Week high

$21.71

52 Week high$21.71

52 Week low

$3.42

52 Week low$3.42

URGN News

TipRanks 3d

UroGen Pharma’s UGN-104 Study: A Potential Game-Changer in Urothelial Cancer Treatment

Urogen Pharma ((URGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Un...

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

People also own

Based on the portfolios of people who own URGN. This list is generated using Robinhood data, and it’s not a recommendation.